Emmett Investment Management LP acquired a new stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 23,875 shares of the financial services provider's stock, valued at approximately $5,544,000. CME Group makes up about 5.0% of Emmett Investment Management LP's investment portfolio, making the stock its 7th largest position.
Several other hedge funds and other institutional investors also recently made changes to their positions in CME. Lake Street Advisors Group LLC raised its position in CME Group by 108.7% during the fourth quarter. Lake Street Advisors Group LLC now owns 12,390 shares of the financial services provider's stock valued at $2,949,000 after acquiring an additional 6,453 shares in the last quarter. Meyer Handelman Co. bought a new position in CME Group during the fourth quarter valued at approximately $6,144,000. Unified Investment Management bought a new position in CME Group during the fourth quarter valued at approximately $503,000. Spire Wealth Management raised its position in CME Group by 37.4% during the fourth quarter. Spire Wealth Management now owns 1,320 shares of the financial services provider's stock valued at $307,000 after acquiring an additional 359 shares in the last quarter. Finally, AEGON ASSET MANAGEMENT UK Plc raised its position in CME Group by 19.3% during the fourth quarter. AEGON ASSET MANAGEMENT UK Plc now owns 326,098 shares of the financial services provider's stock valued at $75,730,000 after acquiring an additional 52,862 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
CME has been the topic of several recent research reports. UBS Group raised their price objective on shares of CME Group from $290.00 to $305.00 and gave the company a "buy" rating in a research report on Friday, April 25th. Royal Bank of Canada reissued a "sector perform" rating and issued a $269.00 price target on shares of CME Group in a research report on Thursday, April 3rd. Bank of America lifted their price target on shares of CME Group from $200.00 to $219.00 and gave the company an "underperform" rating in a research report on Wednesday, April 2nd. Morgan Stanley lifted their price target on shares of CME Group from $301.00 to $304.00 and gave the company an "overweight" rating in a research report on Thursday, April 24th. Finally, Erste Group Bank raised shares of CME Group to a "strong-buy" rating in a research report on Monday, March 17th. Three analysts have rated the stock with a sell rating, seven have issued a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat, CME Group has an average rating of "Hold" and a consensus price target of $256.80.
View Our Latest Research Report on CME
Insiders Place Their Bets
In other CME Group news, insider Hilda Harris Piell sold 3,984 shares of CME Group stock in a transaction on Thursday, February 27th. The stock was sold at an average price of $250.47, for a total transaction of $997,872.48. Following the completion of the transaction, the insider now directly owns 27,046 shares of the company's stock, valued at approximately $6,774,211.62. This trade represents a 12.84% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Suzanne Sprague sold 1,500 shares of CME Group stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $256.83, for a total value of $385,245.00. Following the transaction, the chief operating officer now directly owns 8,036 shares of the company's stock, valued at approximately $2,063,885.88. The trade was a 15.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 34,726 shares of company stock worth $8,975,813 over the last 90 days. Corporate insiders own 0.30% of the company's stock.
CME Group Stock Performance
Shares of CME Group stock traded up $2.36 during midday trading on Friday, hitting $284.35. The company had a trading volume of 953,386 shares, compared to its average volume of 2,155,183. The business's 50 day simple moving average is $264.47 and its two-hundred day simple moving average is $245.78. The stock has a market cap of $102.47 billion, a PE ratio of 29.41, a P/E/G ratio of 6.76 and a beta of 0.45. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $286.48.
CME Group (NASDAQ:CME - Get Free Report) last announced its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.61 by $0.19. CME Group had a net margin of 57.52% and a return on equity of 13.62%. The business had revenue of $1.64 billion for the quarter, compared to the consensus estimate of $1.56 billion. During the same quarter last year, the company posted $2.50 earnings per share. CME Group's quarterly revenue was up 10.4% on a year-over-year basis. As a group, equities analysts predict that CME Group Inc. will post 10.49 EPS for the current fiscal year.
CME Group Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th will be paid a dividend of $1.25 per share. The ex-dividend date is Monday, June 9th. This represents a $5.00 dividend on an annualized basis and a yield of 1.76%. CME Group's dividend payout ratio is currently 50.30%.
CME Group Profile
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Read More

Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report